These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2316237)

  • 1. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic.
    Forstrom MJ; Ried LD; Stergachis AS; Corliss DA
    DICP; 1990 Mar; 24(3):304-9. PubMed ID: 2316237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clinical pharmacists on drug prescribing in a primary-care clinic.
    Stergachis A; Fors M; Wagner EH; Sims DD; Penna P
    Am J Hosp Pharm; 1987 Mar; 44(3):525-9. PubMed ID: 3565410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kaiser Permanente/USC Patient Consultation Study: change in use and cost of health care services.
    McCombs JS; Liu G; Shi J; Feng W; Cody M; Parker JP; Nichol MB; Hay JW; Johnson KA; Groshen SL; Nye MT
    Am J Health Syst Pharm; 1998 Dec; 55(23):2485-99. PubMed ID: 9853633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.
    Polgreen LA; Han J; Carter BL; Ardery GP; Coffey CS; Chrischilles EA; James PA
    Hypertension; 2015 Dec; 66(6):1145-51. PubMed ID: 26527048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacist-delivered Medicare Annual Wellness Visits within a family medicine practice.
    Evans TA; Fabel PH; Ziegler B
    J Am Pharm Assoc (2003); 2017; 57(3S):S247-S251. PubMed ID: 28400254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacists help HMO cut drug costs.
    Knowlton CH; Knapp DA
    Am Pharm; 1994 Jan; NS34(1):36-42. PubMed ID: 8166034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacy services in family practice: cost-benefit analysis. II. Referrals, appointment compliance, and costs.
    Chrischilles EA; Helling DK; Rowland CR
    Drug Intell Clin Pharm; 1984 May; 18(5):436-41. PubMed ID: 6426919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
    Borenstein JE; Graber G; Saltiel E; Wallace J; Ryu S; Archi J; Deutsch S; Weingarten SR
    Pharmacotherapy; 2003 Feb; 23(2):209-16. PubMed ID: 12587810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists.
    Haxby DG; Weart CW; Goodman BW
    Am J Hosp Pharm; 1988 Apr; 45(4):824-7. PubMed ID: 3376965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril to lisinopril: economic impact of a voluntary angiotensin-converting enzyme-inhibitor substitution program in a staff-model health maintenance organization.
    McDonough KP; Weaver RH; Viall GD
    Ann Pharmacother; 1992 Mar; 26(3):399-404. PubMed ID: 1313320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
    Lobas NH; Lepinski PW; Abramowitz PW
    Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decentralized pharmacists in an HMO.
    Mountford G; Warner E; Adkins C
    HMO Pract; 1993 Sep; 7(3):136-8. PubMed ID: 10128835
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacist-managed hypertension therapy conversion.
    Yanchick JK
    Mil Med; 2001 Oct; 166(10):866-70. PubMed ID: 11603236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and cost of drugs in a pharmaceutically decentralized health maintenance organization.
    Hardigan WD; Slywka GW; Eng HJ
    Contemp Pharm Pract; 1980; 3(1):23-30. PubMed ID: 10245109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
    Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
    JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of treating high blood pressure in general practice in France.
    Tibi-Levy Y; de Pouvourville G; Westerloppe J; Bamberger M
    Eur J Health Econ; 2008 Aug; 9(3):229-36. PubMed ID: 17566802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.